Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 105
Filtrar
1.
Int Rev Neurobiol ; 131: 91-126, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27793228

RESUMO

It is now understood that gut bacteria exert effects beyond the local boundaries of the gastrointestinal tract to include distant tissues and overall health. Prototype probiotic bacterium Lactobacillus reuteri has been found to upregulate hormone oxytocin and systemic immune responses to achieve a wide array of health benefits involving wound healing, mental health, metabolism, and myoskeletal maintenance. Together these display that the gut microbiome and host animal interact via immune-endocrine-brain signaling networks. Such findings provide novel therapeutic strategies to stimulate powerful homeostatic pathways and genetic programs, stemming from the coevolution of mammals and their microbiome.


Assuntos
Transtornos Mentais , Obesidade , Ocitocina/uso terapêutico , Probióticos/uso terapêutico , Animais , Trato Gastrointestinal/efeitos dos fármacos , Trato Gastrointestinal/metabolismo , Trato Gastrointestinal/microbiologia , Humanos , Transtornos Mentais/microbiologia , Transtornos Mentais/prevenção & controle , Obesidade/microbiologia , Obesidade/prevenção & controle , Ocitocina/metabolismo
2.
Diabet Med ; 31(9): 1114-20, 2014 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-24825001

RESUMO

AIM: To evaluate adherence to the 2012 Infectious Diseases Society of America practice guidelines for the management of patients with diabetic foot infections and to determine an association between adherence and clinical outcome. METHODS: A retrospective chart review was performed to evaluate the management and clinical outcomes of patients with diabetic foot infections treated with outpatient parenteral antimicrobial therapy between 1 January 2011 and 30 June 2012 at Wishard Health Services/Eskenazi Health. Adherence to individual Infectious Diseases Society of America diabetic foot infection treatment guideline recommendations was measured, and then assessed in relation to clinical outcome. RESULTS: A total of 57 patients (61% male, mean age 54 years) with moderate to severe diabetic foot infection met the inclusion criteria. None of the treatment courses of these patients adhered to all the Infectious Diseases Society of America guideline recommendations. The recommendations most frequently adhered to were consultation of appropriate multidisciplinary teams (n=54, 94.7%) and performance of diagnostic imaging (n=52, 89.5%). The recommendations least frequently adhered to were diabetic foot wound classification scoring on admission (n=0, 0%), appropriate culture acquisition (n=12, 21.2%), surgical intervention when indicated (n=32, 46.2%) and appropriate empiric antibiotic selection (n=34, 59.7%). Of 56 patients, 52 (92.9%) experienced clinical cure at the end of outpatient parenteral antimicrobial therapy compared with 34 of 53 patients (64%) at 6 months after the completion of therapy. Adherence to individual guidelines was not associated with clinical outcome. Patients who experienced treatment failure were more likely to have severe diabetic foot infection or peripheral neuropathy. CONCLUSIONS: Adherence to the Infectious Diseases Society of America diabetic foot infection guideline recommendations was found to be suboptimal in the present study. The effect of adhering to individual Infectious Diseases Society of America diabetic foot infection recommendations on clinical outcome needs to be investigated.


Assuntos
Antibacterianos/uso terapêutico , Infecções Bacterianas/tratamento farmacológico , Pé Diabético/tratamento farmacológico , Hemoglobinas Glicadas/metabolismo , Fidelidade a Diretrizes , Úlcera/microbiologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Infecções Bacterianas/diagnóstico , Infecções Bacterianas/microbiologia , Desbridamento , Pé Diabético/diagnóstico , Pé Diabético/microbiologia , Feminino , Humanos , Indiana/epidemiologia , Masculino , Pessoa de Meia-Idade , Guias de Prática Clínica como Assunto , Estudos Retrospectivos , Fatores de Risco , Resultado do Tratamento
3.
Benef Microbes ; 5(2): 109-19, 2014 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-24675231

RESUMO

Radiant skin and hair are universal indicators of good health. It was recently shown that feeding of probiotic bacteria to aged mice rapidly induced youthful vitality characterised by thick lustrous skin and hair, and enhanced reproductive fitness, not seen in untreated controls. Probiotic-treated animals displayed integrated immune and hypothalamic-pituitary outputs that were isolated mechanistically to microbe-induced anti-inflammatory interleukin-10 and neuropeptide hormone oxytocin. In this way, probiotic microbes interface with mammalian physiological underpinnings to impart superb physical and reproductive fitness displayed as radiant and resilient skin and mucosae, unveiling novel strategies for integumentary health.


Assuntos
Interleucinas/metabolismo , Ocitocina/metabolismo , Probióticos/administração & dosagem , Dermatopatias/prevenção & controle , Fenômenos Fisiológicos da Pele , Animais , Camundongos
4.
Mucosal Immunol ; 4(1): 22-30, 2011 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-20944559

RESUMO

Pioneering work in the 1990s first linked a novel microaerobic bacterium, Helicobacter hepaticus, with chronic active hepatitis and inflammatory bowel disease in several murine models. Targeted H. hepaticus infection experiments subsequently demonstrated its ability to induce colitis, colorectal cancer, and extraintestinal diseases in a number of mouse strains with defects in immune function and/or regulation. H. hepaticus is now widely utilized as a model system to dissect how intestinal microbiota interact with the host to produce both inflammatory and tolerogenic responses. This model has been used to make important advances in understanding factors that regulate both acquired and innate immune response within the intestine. Further, it has been an effective tool to help define the function of regulatory T cells, including their ability to directly inhibit the innate inflammatory response to gut microbiota. The complete genomic sequence of H. hepaticus has advanced the identification of several virulence factors and aided in the elucidation of H. hepaticus pathogenesis. Delineating targets of H. hepaticus virulence factors could facilitate novel approaches to treating microbially induced lower bowel inflammatory diseases.


Assuntos
Neoplasias Colorretais , Modelos Animais de Doenças , Infecções por Helicobacter , Helicobacter hepaticus , Interações Hospedeiro-Patógeno , Doenças Inflamatórias Intestinais , Trato Gastrointestinal Inferior , Animais , Neoplasias Colorretais/microbiologia , Neoplasias Colorretais/patologia , Infecções por Helicobacter/imunologia , Infecções por Helicobacter/microbiologia , Infecções por Helicobacter/patologia , Helicobacter hepaticus/genética , Helicobacter hepaticus/imunologia , Helicobacter hepaticus/patogenicidade , Doenças Inflamatórias Intestinais/imunologia , Doenças Inflamatórias Intestinais/microbiologia , Doenças Inflamatórias Intestinais/patologia , Trato Gastrointestinal Inferior/imunologia , Trato Gastrointestinal Inferior/microbiologia , Trato Gastrointestinal Inferior/patologia , Camundongos , Úlcera Péptica/microbiologia , Linfócitos T/imunologia , Fatores de Virulência
5.
J Investig Allergol Clin Immunol ; 19(5): 355-69, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19862935

RESUMO

BACKGROUND: We present the results obtained from the largest series of in vitro diagnostic tests ever reported in patients with clinically validated hypersensitivity to acetylsalicylic acid (ASA)/nonsteroidal anti-inflammatory drugs (NSAID) compared with various categories of controls tolerating ASA/NSAIDs. This multicenter study, which was performed within the framework of the European Network for Drug Allergy (ENDA) group, showed that the basophil activation test (BAT), particularly when used with the 3 NSAIDs aspirin (ASA), diclofenac (DIC), and naproxen (NAP), allows us to confirm the diagnosis of NSAID hypersensitivity syndrome. The results of the cellular allergen stimulation test (CAST) frequently correlate with those of the BAT, although not always. An unexpected finding was that basophil activation by NSAIDs is not an all-or-nothing phenomenon restricted to clinically hypersensitive patients, but that it also occurs in a dose-related manner in some NSAID-tolerant control individuals.Therefore, NSAID hypersensitivity appears as a shift in the normal pharmacological response to NSAIDs. These findings allow us to formulate a new rational hypothesis about the mechanism of NSAID hypersensitivity syndrome, a mechanism that most authors continue to describe as "unknown." METHODS: We enrolled 152 patients with a history of hypersensitivity to NSAIDs and 136 control participants in 11 different centers between spring 2003 and spring 2006. Flowcytometric BAT was performed. RESULTS: The most noteworthy results of our study were that 57% of 140 patients presented very clear-cut positive BAT results to multiple NSAIDs, and 16% were entirely negative. In about 27% of cases, positive results were obtained with 1 or 2 concentrations of a single NSAID. There is clearly a correlation between the results of BAT and CAST. CONCLUSIONS: BAT seems particularly indicated in patients with a clinical history of NSAID intolerance, and in whom a provocation test is not advisable for ethical, clinical, or other reasons. Clear-cut positive results can be considered as confirming a history of NSAID hypersensitivity, although negative results may not exclude it.


Assuntos
Anti-Inflamatórios não Esteroides/efeitos adversos , Anti-Inflamatórios não Esteroides/imunologia , Hipersensibilidade a Drogas/imunologia , Adolescente , Adulto , Idoso , Aspirina/efeitos adversos , Aspirina/imunologia , Basófilos/citologia , Basófilos/imunologia , Diclofenaco/efeitos adversos , Diclofenaco/imunologia , Hipersensibilidade a Drogas/diagnóstico , Feminino , Citometria de Fluxo/métodos , Humanos , Leucotrienos/sangue , Ativação Linfocitária , Masculino , Pessoa de Meia-Idade , Naproxeno/efeitos adversos , Naproxeno/imunologia , Curva ROC , Sensibilidade e Especificidade , Adulto Jovem
6.
Proc Natl Acad Sci U S A ; 106(4): 1027-32, 2009 Jan 27.
Artigo em Inglês | MEDLINE | ID: mdl-19164562

RESUMO

Recombinase-activating gene-2-deficient (Rag2(-/-)) mice lacking functional lymphocytes provide a useful model of chronic inflammatory bowel disease-emulating events in human colon cancer. Infection of Rag2(-/-) mice with Helicobacter hepaticus led to accumulation of macrophages and neutrophils in the colon, a process temporally related to up-regulation of tissue inducible nitric oxide synthase (iNOS) expression at the site of infection and increased nitric oxide (NO) production, as evidenced by urinary excretion of nitrate. Progressive development of increasingly severe inflammation, hyperplasia, dysplasia, and cancer accompanied these changes. Concurrent administration of an iNOS inhibitor prevented NO production and abrogated epithelial pathology and inhibited the onset of cancer. The presence of Gr-1(+) neutrophils and elevated tumor necrosis factor-alpha (TNF-alpha) expression in colon were required for increased iNOS expression and cancer, whereas interleukin-10 (IL-10) down-regulated TNF-alpha and iNOS expression and suppressed cancer. Anti-inflammatory CD4(+) regulatory lymphocytes also down-regulated iNOS and reduced cancer formation. Collectively, these results confirm essential roles for inflammation, increased TNF-alpha expression, and elevated NO production in colon carcinogenesis.


Assuntos
Colo/patologia , Neoplasias do Colo/patologia , Proteínas de Ligação a DNA/deficiência , Infecções por Helicobacter/microbiologia , Helicobacter hepaticus/imunologia , Óxido Nítrico/metabolismo , Fator de Necrose Tumoral alfa/metabolismo , Animais , Arginina/farmacologia , Colo/enzimologia , Colo/imunologia , Colo/microbiologia , Neoplasias do Colo/complicações , Neoplasias do Colo/imunologia , Neoplasias do Colo/microbiologia , Proteínas de Ligação a DNA/metabolismo , Inibidores Enzimáticos/farmacologia , Infecções por Helicobacter/enzimologia , Infecções por Helicobacter/imunologia , Infecções por Helicobacter/urina , Inflamação/imunologia , Inflamação/microbiologia , Mediadores da Inflamação/metabolismo , Camundongos , Nitratos/urina , Óxido Nítrico Sintase Tipo II/antagonistas & inibidores , Óxido Nítrico Sintase Tipo II/metabolismo
7.
Vet Pathol ; 39(2): 173-9, 2002 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-12009055

RESUMO

Hepatobiliary disease was diagnosed in eight of 34 genetically unrelated cohabitating pet ferrets (Mustela putorios furo) during a 7-year period. The eight ferrets ranged in age from 5 to 8 years and exhibited chronic cholangiohepatitis coupled with cellular proliferation ranging from hyperplasia to frank neoplasia. Spiral-shaped argyrophilic bacteria were demonstrated in livers of three ferrets, including two with carcinoma. Sequence analysis of a 400-base pair polymerase chain reaction product amplified from DNA derived from fecal bacteria from one ferret demonstrated 98% and 97% similarity to Helicobacter cholecystus and Helicobacter sp. strain 266-1 , respectively. The clustering of severe hepatic disease in these cohabitating ferroes suggests a possible infectious etiology. The role of Helicobacter species and other bacteria in hepatitis and/or neoplasia in ferrets requires further study.


Assuntos
Doenças Biliares/veterinária , Furões , Infecções por Helicobacter/veterinária , Helicobacter pylori/isolamento & purificação , Hepatopatias/veterinária , Animais , Neoplasias dos Ductos Biliares/etiologia , Neoplasias dos Ductos Biliares/microbiologia , Neoplasias dos Ductos Biliares/patologia , Neoplasias dos Ductos Biliares/veterinária , Ductos Biliares/patologia , Doenças Biliares/microbiologia , Doenças Biliares/patologia , Colangiocarcinoma/etiologia , Colangiocarcinoma/microbiologia , Colangiocarcinoma/patologia , Colangiocarcinoma/veterinária , Cistadenoma/microbiologia , Cistadenoma/patologia , Cistadenoma/veterinária , DNA Bacteriano/análise , Feminino , Infecções por Helicobacter/complicações , Helicobacter pylori/genética , Hepatite Animal/microbiologia , Hepatite Animal/patologia , Hiperplasia/veterinária , Imuno-Histoquímica/veterinária , Fígado/microbiologia , Hepatopatias/microbiologia , Hepatopatias/patologia , Masculino , Reação em Cadeia da Polimerase/veterinária
8.
Genetics ; 159(3): 919-28, 2001 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11729141

RESUMO

Haploid cells of the budding yeast Saccharomyces cerevisiae respond to mating pheromones by arresting their cell-division cycle in G1 and differentiating into a cell type capable of locating and fusing with mating partners. Yeast cells undergo chemotactic cell surface growth when pheromones are present above a threshold level for morphogenesis; however, the morphogenetic responses of cells to levels of pheromone below this threshold have not been systematically explored. Here we show that MATa haploid cells exposed to low levels of the alpha-factor mating pheromone undergo a novel cellular response: cells modulate their division patterns and cell shape, forming colonies composed of filamentous chains of cells. Time-lapse analysis of filament formation shows that its dynamics are distinct from that of pseudohyphal growth; during pheromone-induced filament formation, daughter cells are delayed relative to mother cells with respect to the timing of bud emergence. Filament formation requires the RSR1(BUD1), BUD8, SLK1/BCK1, and SPA2 genes and many elements of the STE11/STE7 MAP kinase pathway; this response is also independent of FAR1, a gene involved in orienting cell polarization during the mating response. We suggest that mating yeast cells undergo a complex response to low levels of pheromone that may enhance the ability of cells to search for mating partners through the modification of cell shape and alteration of cell-division patterns.


Assuntos
Genes Fúngicos , Feromônios/farmacologia , Saccharomyces cerevisiae/fisiologia , Divisão Celular , Fase G1 , Haploidia , Microscopia de Vídeo , Feromônios/metabolismo , Saccharomyces cerevisiae/metabolismo , Transdução de Sinais , Fatores de Tempo
9.
J Immunol ; 166(3): 1443-7, 2001 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-11160181

RESUMO

Activation of inflammatory gene expression by the transcription factor NF-kappaB is a central pathway in many inflammatory disorders, including colitis. Increased NF-kappaB activity has been linked with development of colitis in humans and animal models, thus it was unexpected when NF-kappaB-deficient mice developed spontaneous typhlocolitis. To further characterize this finding, we induced typhlocolitis in rederived NF-kappaB-deficient mice using intragastric infection with Helicobacter hepaticus. At 6 wk postinfection (PI), severe colitis with increased type 1 cytokine expression was seen in infected mice that lacked the p50 subunit of NF-kappaB and were also heterozygous for the p65 subunit of NF-kappaB(p50(-/-)p65(+/-)). Mice lacking the p50 subunit alone (p50(-/-)) were less severely affected, and wild-type mice and p65(+/-) mice were unaffected. T cell development in NF-kappaB-deficient mice was normal. These data indicate that p50 and p65 subunits of NF-kappaB have an unexpected role in inhibiting the development of colitis.


Assuntos
Colite/genética , NF-kappa B/deficiência , NF-kappa B/genética , Animais , Colite/imunologia , Colite/patologia , Colo/imunologia , Colo/metabolismo , Colo/patologia , Citocinas/biossíntese , Citocinas/genética , Regulação da Expressão Gênica/imunologia , Predisposição Genética para Doença , Infecções por Helicobacter/genética , Infecções por Helicobacter/imunologia , Infecções por Helicobacter/patologia , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Subunidade p50 de NF-kappa B , Especificidade de Órgãos/genética , Especificidade de Órgãos/imunologia , RNA Mensageiro/biossíntese , Organismos Livres de Patógenos Específicos , Fator de Transcrição RelA
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA